Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Durability of Response to Venetoclax (VEN) in Patients with CLL Relapsed/Refractory to Ibrutinib and/or Idelalisib Byrd, J., Wierda, W., Davids, M., Choi, M., Furman, R., Mato, A., Zhou, L., Verdugo, M., Potluri, J., Coutre, S. WILEY. 2019: 83–84
View details for Web of Science ID 000462529200122